Sun Pharma’s Organon debt refinancing
Sun Pharma plans to raise about ₹10,000 crore through rupee-denominated bonds, partly to refinance a bridge loan used for its Organon acquisition. The bonds are expected to mature in two, three and four years.
Timeline
Tuesday, 29 September
- Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report
Sun Pharma plans a ₹10,000 crore bond sale to refinance its Organon deal
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Sun Pharma plans to raise about ₹10,000 crore through rupee-denominated bonds
